Protective effects of Astragalus polysaccharides on isoproterenol induced myocardial hypertrophy in neonatal rats

Chinese Pharmacological Bulletin

Volumn 27, Issue 12, 2011, Pages 1682-1686

  Zhao, Su Ling ^a   Wang, Hong Xin ^a   Zhou, Zhen Hua ^a   Yu, Xiao Chun ^b   Lu, Mei Li ^a   Song, Ying ^a   Zhang, Jing ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

ANP; Astragalus polysaccharides; Calcium concentration; Isoproterenol; Myocardial hypertrophy; Protective effect

Indexed keywords

ASTRAGALUS EXTRACT; ASTRAGALUS POLYSACCHARIDE; CALCIUM ION; ISOPRENALINE; POLYSACCHARIDE; PROTECTIVE AGENT; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84863149570     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2011.12.013     Document Type: Article

References (11)

1. Shao B M, Xu W, Dai H, et al. A study on the immune receptors for polysacch-arides from the roots of Astragalus membranaceus. a Chinese medicinal herb[ J]. Biochem Biophys Res Commun, 2004,320 (4):1103-11.
2. Min Q, Bai Y T, Yu W, et al. Protective effects of Astragalus polysaccharide on cultured myocardial cells subjected to anoxia/reoxygenation injury in neonatal rats[J]. Chin Pharmacol Bull, 2010,26(12):1661-4.
3. Shan D, Wang H X, Yang Y H, et al. κ-opioid receptor stimulation inhibits cardiac hypertrophy induced by β1-adrenoceptor stimulation in the rat[J]. Eur J Pharmacol, 2007, 555(2-3): 100-5.
4. 2+-transport [J]. Circ Res, 2003,92(7):769-76.
5. Gaasch W H, Delorey D E, St John Sutton M G, Zile M R. Patterns of structural and functional remodeling of the left ventricle in chronic heart failure[J]. Am J Cardiol, 2008,102(4):459-62.
6. Calderone A, Takahashi N, Izzo NJ Jr, et al. Pressure-and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs[J]. Circulation, 1995,92(9):2385-90.
7. Miyatake S, Manabe-Kawaguchi H, Watanabe K, et al. Prostaglandin E2 induces hypertrophic changes and suppresses alpha-skeletal actin gene expression in rat cardiomyocytes[J]. Cardiovasc Pharmacol,2007,50(5):548-54.
8. Bers D M, Guo T. Calcium signaling in cardiac ventricular myocytes[J]. Ann N Y Acad Sci, 2005,1047:86-98.
9. Liu C Z, Tan J X, Wang Y, et al. L-type calcium channel blocker suppresses calcineurin signal pathway and development of right ventricular hypertrophy[J]. Formas Med Assoc, 2005,104(11):798-803.
10. Su D, Xu B, Shi L H, et al. Effect of astragaluson calcium acccumulation and SERCA2a gene expression in myocardial tissues in rats with press overload-induced left Ventricular hypertrophy[J]. China J Chin Mat Med, 2008,33(14):1724-7.
11. Wang Q N, Wang H X, Yang Y H, et al. Protective effect of astragalus IV on isoproterenol-induced myocardial hypertrophy[J]. Chin J Pharmacol Toxicol, 2011,25(1):29-33.